<narrative>Expanding and enhancing quality TB prevention, care and control services in South Sudan - South Sudan (01-Jul-2015-31-Dec-2017)</narrative>

47045-SSD-T-UNDP-1

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>Expanding and enhancing quality TB prevention, care and control services in South Sudan - South Sudan (01-Jul-2015-31-Dec-2017)</narrative> South Sudan, Tuberculosis, United Nations Development Programme Goal: To contribute to achieving the goal aimed by the national policy to control TB and emphasized in the 2015-2019 NSP: to reduce by 30% the TB prevalence (based on the WHO estimates) by 2030. Objectives: To enroll on second line TB drug treatment 20 MDR-TB patients in 2015, 40 in 2016 and 75 in 2017, and to successifully treat 70% of them; To improve and reinforce the technical and managerial capacities of the NTP; To increase the number of TB cases annually notified to reach 15,150 by 2017; To increase treatment success rate of bacteriologically confirmed TB cases from 72% in 2012 to 85% in 2017; To reduce death rate from 11% in 2012 to 5% in 2017 in HIV co-infected TB patients who received TB treatment.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

xxxx xxxx

Fund Portfolio Manager

+41 58 791 1700 xxxx https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

South Sudan

Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases

5884899.00 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3726640.00 Global Fund disbursement to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2158259.00 Global Fund disbursement to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2991662.00 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

937840.00 Global Fund disbursement to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1813700.00 Global Fund disbursement to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

240122.00 Global Fund disbursement to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

3509411.00 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1125475.00 Global Fund disbursement to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1273003.00 Global Fund disbursement to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1825474.00 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-1110933.00 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1825474.00 Global Fund disbursement to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

900087.00 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

900087.00 Global Fund disbursement to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-25000.00 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

96188.85 Funds returned to the Global Fund from SSD-T-UNDPP01.

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-96188.85 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

31224.50 Funds returned to the Global Fund from SSD-T-UNDPP01.

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-31224.50 Global Fund commitment to SSD-T-UNDPP01.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 0; Denominator: 16; Percentage: 0%.

Numerator: 0. Numerator: 0.

Numerator: 2. Numerator: 0; Denominator: 0; Percentage: 0%.

Numerator: 3. Numerator: 0; Denominator: 3; Percentage: 0%.

Numerator: 5. Numerator: 12; Percentage: 120%.

Numerator: 5. Numerator: 6; Denominator: 5; Percentage: 120%.

<narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Module: MDR-TB. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 98; Denominator: 371.

Numerator: 74; Denominator: 245. Numerator: 46; Denominator: 234.

Numerator: 158; Denominator: 315. Numerator: 68; Denominator: 273.

Numerator: 158; Denominator: 315. Numerator: 105; Denominator: 266.

Numerator: 212; Denominator: 424. Numerator: 126; Denominator: 483.

Numerator: 212; Denominator: 424. Numerator: 83; Denominator: 295.

<narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 49; Denominator: 65.

Numerator: 130; Denominator: 174. Numerator: 148; Denominator: 151.

Numerator: 174; Denominator: 174. Numerator: 148; Denominator: 152.

Numerator: 234; Denominator: 234. Numerator: 147; Denominator: 148.

Numerator: 199; Denominator: 234. Numerator: 154; Denominator: 160.

Numerator: 250; Denominator: 294. Numerator: 192; Denominator: 192.

<narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 6959.

Numerator: 5162. Numerator: 5431.

Numerator: 5586. Numerator: 5880; Percentage: 105%.

Numerator: 5586. Numerator: 5821; Denominator: 5586; Percentage: 104.2%.

Numerator: 6287. Numerator: 6546; Percentage: 104%.

Numerator: 6287. Numerator: 6367.

<narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Module: TB care and prevention. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 3203.

Numerator: 2656. Numerator: 2299.

Numerator: 3098. Numerator: 2838; Percentage: 92%.

Numerator: 3098. Numerator: 2830; Denominator: 3098; Percentage: 91.4%.

Numerator: 3839. Numerator: 3290; Percentage: 86%.

Numerator: 3839. Numerator: 3132.

<narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Module: TB care and prevention. <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1998; Denominator: 2767.

Numerator: 1480; Denominator: 1850. Numerator: 1382; Denominator: 1775.

Numerator: 2178; Denominator: 2656. Numerator: 1713; Denominator: 2213.

Numerator: 2178; Denominator: 2656. Numerator: 1635; Denominator: 2178.

Numerator: 2633; Denominator: 3098. Numerator: 1854; Denominator: 2838.

Numerator: 2633; Denominator: 3098. Numerator: 4638; Denominator: 5821.

<narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 26; Denominator: 29.

Numerator: 38; Denominator: 40. Numerator: 61; Denominator: 73.

Numerator: 57; Denominator: 60. Numerator: 76; Denominator: 89.

Numerator: 76; Denominator: 80. Numerator: 33; Denominator: 37.

Numerator: 95; Denominator: 100. Numerator: 36; Denominator: 38.

Numerator: 114; Denominator: 120. Numerator: 48; Denominator: 64.

<narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 5557; Denominator: 7432.

Numerator: 3452; Denominator: 4315. Numerator: 3575; Denominator: 4521.

Numerator: 4233; Denominator: 5162. Numerator: 4177; Denominator: 5178.

Numerator: 4233; Denominator: 5162. Numerator: 4119; Denominator: 5033.

Numerator: 4748; Denominator: 5586. Numerator: 3979; Denominator: 5880.

Numerator: 4748; Denominator: 5586. Numerator: 2207; Denominator: 2830.

<narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 236; Denominator: 669.

Numerator: 271; Denominator: 542. Numerator: 302; Denominator: 459.

Numerator: 469; Denominator: 670. Numerator: 363; Denominator: 559.

Numerator: 469; Denominator: 670. Numerator: 399; Denominator: 525.

Numerator: 764; Denominator: 849. Numerator: 444; Denominator: 621.

Numerator: 764; Denominator: 849. Numerator: 552; Denominator: 647.

<narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Module: TB/HIV. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 4462; Denominator: 6959.

Numerator: 3613; Denominator: 5162. Numerator: 3945; Denominator: 5431.

Numerator: 4468; Denominator: 5586. Numerator: 4506; Denominator: 5880.

Numerator: 4468; Denominator: 5586. Numerator: 4691; Denominator: 5821.

Numerator: 5658; Denominator: 6287. Numerator: 5066; Denominator: 6546.

Numerator: 5658; Denominator: 6287. Numerator: 5171; Denominator: 6367.

47045-SSD-T-UNDP-2

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative>Expanding and enhancing quality TB prevention, care and control services in South Sudan - South Sudan (01-Jan-2018-31-Dec-2020)</narrative> South Sudan, Tuberculosis, United Nations Development Programme Goal: To reduce the TB prevalence by 30% from 257/100,000 to 180/100,000 (WHO estimate 2012)prevalence by 2020. Objectives: Increase TB cases notified to 13,000; 15,500 and 18,000 in year one, two and three respectively; Increase treatment success rate from 71% for new and relapsed cases registered in 2014 to at least 85% by 2019; Detect and enrol MDR/RR-TB patients on second line treatment and achieve a treatment success rate of at least 55% by 2020; Reduce death rate of TB/HIV co-infected patients from 10% in 2016 to less than 2% in 2020; Strengthen NTP operations in order to achieve at least 80% of programme targets.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division

xxxx xxxx

Fund Portfolio Manager

+41 58 791 1700 xxxx https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

South Sudan

Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Health management information systems and M&E -> Other health information systems and M&E intervention(s)

RSSH -> RSSH: Health management information systems and M&E -> Program and data quality

RSSH -> RSSH: Health management information systems and M&E -> Routine reporting

Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB)

Tuberculosis -> MDR-TB -> Prevention (MDR-TB)

Tuberculosis -> MDR-TB -> Treatment (MDR-TB)

Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention)

Tuberculosis -> TB care and prevention -> Community TB care delivery

Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Others

Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention)

Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions

2350445.42

3488626.39

5512132.14

4987677.07 Global Fund commitment to SSD-T-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1096925.41 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to SSD-T-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1200842.00 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

979736.00 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to SSD-T-UNDPP02 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

574228.00 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to SSD-T-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

481974.00 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

-653971.66 Global Fund commitment to SSD-T-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2672161.58 Global Fund commitment to SSD-T-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1490177.00 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1181984.58 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to SSD-T-UNDPP02 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1219334.00 Global Fund commitment to SSD-T-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

1219334.00 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund commitment to SSD-T-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2326203.97 Global Fund commitment to SSD-T-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

989893.00 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

790037.00 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

546273.97 Global Fund disbursement to SSD-T-UNDPP02 (Multilateral).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

25000.00 Global Fund disbursement to SSD-T-UNDPP02 (Other 3rd Party).

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2.81 Funds returned to the Global Fund from SSD-T-UNDPP02 (Multilateral).

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

-2.81 Global Fund commitment to SSD-T-UNDPP02.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

2350445.42 Expenditure reported by United Nations Development Programme for SSD-T-UNDPP02, Jan 2018 to Dec 2018.

United Nations Development Programme

3488626.39 Expenditure reported by United Nations Development Programme for SSD-T-UNDPP02, Jan 2019 to Dec 2019.

United Nations Development Programme

4890028.63 Expenditure reported by United Nations Development Programme for SSD-T-UNDPP02, Jan 2020 to Dec 2020.

United Nations Development Programme

560970.74 Expenditure reported by United Nations Development Programme for SSD-T-UNDPP02, Jan 2021 to Jun 2021.

United Nations Development Programme

<narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime.

<narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants.

<narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 20.

Numerator: 35. Numerator: 17; Denominator: 35; Percentage: 48.6%.

Numerator: 35. Numerator: 36.

Numerator: 67. Numerator: 34.

Numerator: 68. Numerator: 34.

Numerator: 110. Numerator: 37.

Numerator: 110. Numerator: 63.

Numerator: 35. Numerator: 7; Denominator: 35; Percentage: 20%.

Numerator: 35. Numerator: 21.

Numerator: 67. Numerator: 26.

Numerator: 68. Numerator: 35.

Numerator: 110. Numerator: 24.

Numerator: 110. Numerator: 59.

<narrative>Proportion of facility reports received over the reports expected during the reporting period</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Proportion of facility reports received over the reports expected during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 84; Denominator: 100.

Numerator: 184; Denominator: 204. Numerator: 215; Denominator: 218.

Numerator: 184; Denominator: 204. Numerator: 190; Denominator: 190.

Numerator: 210; Denominator: 234. Numerator: 210; Denominator: 210.

Numerator: 210; Denominator: 234. Numerator: 198; Denominator: 212.

Numerator: 228; Denominator: 254. Numerator: 211; Denominator: 216.

Numerator: 228; Denominator: 254. Numerator: 214; Denominator: 218.

Numerator: 6339. Numerator: 6925; Denominator: 6339; Percentage: 109.2%.

Numerator: 6339. Numerator: 7446; Denominator: 6339; Percentage: 117.5%.

Numerator: 6973. Numerator: 8566.

Numerator: 6973. Numerator: 7757.

Numerator: 10416. Numerator: 7622.

Numerator: 10416. Numerator: 8085.

Numerator: 87; Denominator: 92. Numerator: 68; Denominator: 93.

Numerator: 87; Denominator: 92. Numerator: 62; Denominator: 75.

Numerator: 100; Denominator: 105. Numerator: 44; Denominator: 61.

Numerator: 100; Denominator: 105. Numerator: 76; Denominator: 87.

Numerator: 108; Denominator: 114. Numerator: 76; Denominator: 84.

Numerator: 108; Denominator: 114. Numerator: 77; Denominator: 86.

<narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 740; Denominator: 1094.

Numerator: 550; Denominator: 647. Numerator: 673; Denominator: 757.

Numerator: 550; Denominator: 647. Numerator: 758; Denominator: 822.

Numerator: 678; Denominator: 753. Numerator: 827; Denominator: 941.

Numerator: 678; Denominator: 753. Numerator: 737; Denominator: 822.

Numerator: 831; Denominator: 874. Numerator: 813; Denominator: 865.

Numerator: 831; Denominator: 874. Numerator: 806; Denominator: 838.

<narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 8984; Denominator: 11364.

Numerator: 5378; Denominator: 6339. Numerator: 6086; Denominator: 6925.

Numerator: 5378; Denominator: 6339. Numerator: 7065; Denominator: 7446.

Numerator: 6276; Denominator: 6973. Numerator: 7814; Denominator: 8566.

Numerator: 6276; Denominator: 6973. Numerator: 7291; Denominator: 7757.

Numerator: 7287; Denominator: 7670. Numerator: 7172; Denominator: 7622.

Numerator: 7287; Denominator: 7670. Numerator: 7623; Denominator: 8085.